We’re recruiting. Please help share.

faculty-emory.icims.com/jobs/162521/...

Welcome to sunny Kraków for #ENETS2026!
We are delighted to welcome 1,100 colleagues from across the global #NEN community. The meeting begins today with the 16th ENETS Postgraduate Course and the Basic Science Track.
We wish you an inspiring and productive conference. See you in the sessions!

The Iowa NET SPORE is accepting Letters of Concept for CEP & DRP translational research awards. 4 projects selected, up to $50K each. Open to all U.S. academic institutions.

Deadline: March 23. Apply: uiowa.qualtrics.com/jfe/form/SV_...

Getting my lab up & running @winshipcancer.emory.edu

We focus on neuroendocrine cancers 🧫🧬🔬🦓

Join us in the beautiful city of #Atlanta!

The 5 E’s (of Carcinoid Syndrome) The 5 Es was a good idea but the boundary was never properly defined.  I don't believe it applies to all NETs and I don't believe it is confined to carcinoid syndrome Original Post Since my diagnosis, I seem to have been in a perpetual learning phase! What not to do, what not to eat, what not to read! However, early on in my experience, I came across a list of 'E' words (5 of them) which is a handy reminder for Carcinoid Syndrome patients, particularly those whose symptoms are not under control.

The 5 E's (of Carcinoid Syndrome)

I’m thrilled to announce that I will be joining Emory University @WinshipAtEmory in Feb 2026!

Many thanks to everyone for all your support! 🙏

Looking forward to expanding our neuroendocrine cancer program to better serve the NET community!

@CureNETs @NANETS1 @ENETS_ORG @netcancerfound

It was such a great honor to be at #ENETS2025

I saw so many NET super stars 🤩🤩🤩 but I was too shy to go talk to them.

I finally summed up my courage to ask 2 of them (Profs de Herder & Hofland) for a selfie.

More next time…

@endocrineoncology.bsky.social is in great hands with outstanding expertises from profs Castano & Glasberg!

Preparing for the ENETS annual conference next month. Here is a simplified vision of what might be the future in the world of radioligand therapy for NETs (RLT which I now prefer over PRRT as a term...).

Need better predictors of efficacy and tox

I have never been good at predicting...

Congratulations to our founding member & former ENETS Chair, Philippe Ruszniewski, on receiving the ENETS Life Achievement Award 2025 from ENETS Chair Rocio Garcia-Carbonero. A well-deserved honour for his dedication and lifelong contributions to ENETS & NET science.
Thank you, Philippe!
#ENETS2025

🔥 from #ENETS25 - 🇨🇦 science on a big stage!💪🏻

@iacovosmichael.bsky.social using NETs organoids (my NET babies!) to test new Rx mechanisms
▪️apoptosis machinery active in G1/2 NETs
▪️BH3-mimetics + lutathera work in lab
👉🏻 New therapy to trial?

#NETsky #oncSky @nanets.bsky.social

Care of neuroendocrine tumours: the Collaborative of sUrgical Teams for NeuroEndocrine Tumors (CUTNETs) Neuroendocrine tumours (NETs) are a diverse group of malignancies with rising incidence and complex behaviours1,2. Although surgical management is a critic

Get to know the new CUTNETs group!

Clinical care, research & training to be combined to ⬆️ surgical care of NETs 🇨🇦🇮🇹🇺🇸🇲🇽🇬🇧🇳🇴🇸🇪🇦🇹🇩🇪🇳🇱

Stay tuned for our research agenda and first collaborative studies 🦓🤝

in @bjsurgery.bsky.social 🔗 tinyurl.com/5n6e8w84

#NETSky #SurgSky #OncSky @nanets.bsky.social

Because you can resect does not mean you should

Not all NETs are the same

Stefano Partelli introducing biological unresectability for PNETs at #ENETS25 👉🏻 identifying futile surgery & when preop therapy will help

We have 💊options - let’s figure out how to combine with surgery!

#NETsky #Medsky

We're here at #ENETS2025 with Editor-in-Chief @justocastano.bsky.social , publisher Katherine and publishing assistant Brittany, representing the journal in beautiful Kraków!
If you're attending the conference come tell us about your next publication 🤝

Not many posts yet for #AACR25 in the #OncSky network, but there is bound to be in the run-up to the @theaacr.bsky.social Annual Meeting taking place in 7 weeks in #Chicago.
With increased scientific discourse on #Bluesky in recent weeks/months, looking forward to updates here throughout the meeting

More info on the this upcoming @moltherapy.bsky.social @cellpress.bsky.social Webinar taking place March 18, and the link for free registration:

www.workcast.com/register?cpa...

The content is a good preview for #AACR25 !

📸 Endocrine Oncology publishing team and our Deputy Editor Simona Glasberg ( @simonaglasberg.bsky.social ) at #ENETS2025 in Kraków!

@enets.bsky.social

Day 3 at #ENETS2025! Pictured is Editor-in-Chief Justo Castaño ( @justocastano.bsky.social ) finishing up his talk on best basic science NET publications of the year! ✨ if you’d like to find out more information on Endocrine Oncology visit eo.bioscientifica.com

Our latest Special Collection celebrates the contributions and leadership of women in Neuroendocrine Tumour science, who are breaking barriers and building legacies. Submit your article proposal to contribute to this important collection. Learn more 👉 eo.bioscientifica.com/page/Women-i...

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring Researchers facing “a lot of uncertainty, fear, and panic”

Cancer affects everyone and knows no boundaries. It doesn't know or care about your political affiliations or your political beliefs. #CancerResearch and #Research of all kinds are the lifeblood of progress.
Halting progress without cause is unacceptable.
www.science.org/content/arti...

I’m getting myself more plants & flowers 🪴

Gastroenteropancreatic Neuroendocrine Tumor Incidence by Sex and Age in the US This observational study reports on a comprehensive nationwide evaluation of rising gastroenteropancreatic neuroendocrine tumor incidence in the US from 2001 to 2020.

New epidemiology data on gastroenteropancreatic
NETs (GEP-NETs) in the US. As I have said before and will continue saying, the incidence keeps rising (probably mostly from better diagnostic methods).

jamanetwork.com/journals/jam...

We know about what factors we can avoid, but what ones could we avoid if we knew about them? The role of the gut #microbiome has come under the microscope - Fusobacterium nucleatum and a few other culprits are implicated, but why are they there?
2/n #OnlyOncsInTheSymposium #GI25

🔬 Join #ASOChat: Exploring breakthrough NET research!
Dr. Howe & Dr. Halfdanarson discuss "PRRT Improves Survival in Patients Who Progress After Resection of GEPNETs" - new findings in #JournalASO

📅 Jan 30, 6-7PM EST
📍 Live on X & BlueSky

#NETs #SurgOnc #MedTwitter

AACR President-Elect Lillian Siu, MD, FAACR, explains how precision medicine could advance in 2025, including a new era for drugging the undruggable, better predicting treatment response, and more: www.aacr.org/blog/2025/01...

I’m very honored to be a part of this!

Big thanks to Dr @kelines.bsky.social who brought us together and made it happen! She’s awesome! 👏👏👏

Super exciting! Highly recommended!

Imatinib and the dawn of precision cancer therapy - Nature Medicine Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia.

Imatinib and the dawn of precision cancer therapy

Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia.

www.nature.com/articles/s41...

Happy New Year!
Bonne Année!🥳

My 1st time processing a Merkel Cell Carcinoma: What is that brown paste?